Skip to main content
Clinical Trials/CTRI/2025/01/079428
CTRI/2025/01/079428
Not yet recruiting
Phase 2/3

A RANDOMIZED STUDY TO COMPARE THE EFFECT OF NEBULIZED ROPIVACAINE AND NEBULIZED ROPIVACAINE WITH DEXMEDETOMIDINE ON ATTENUATING HEMODYNAMIC RESPONSE TO INTUBATION IN PATIENTS UNDERGOING SURGERY UNDER GENERAL ANAESTHESIA

Ashu Agarwal1 site in 1 country80 target enrollmentStarted: February 22, 2025Last updated:

Overview

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Ashu Agarwal
Enrollment
80
Locations
1
Primary Endpoint
.To access and compare they hemodynamic changes HR , SBP, DBP,MAP, Spo2 and ETco2 in both the groups

Overview

Brief Summary

THIS STUDY IS TO COMAPRE THEY EFFECT OF NEBULIZED ROPIVACAINE AND NEBULIZED ROPIVACAINE WITH DEXMEDETOMIDINE ON THE HEMODYNAMICE RESPONSE TO INTUBATION IN PATIENTS UNDERGOING SURGERY UNDER GENERAL ANAESTHESIA. PREOPERATIVE VITALS ARE MOINTORED AND BEFORE INTUBATION PATIENTS IS NEBULIZED WITH ONE OF THEY GROPUS AND AFTER NEBULIZATION THEY VITALS ARE MONITORED AND THEY ARE VITALS ARE MOINTORED THROUGH OUT THEY PROCEDURE AT DIFFERENT TIME INTERVAL AND AFTER EXTUBATION PATIENTS IS ACCESED FOR SORE THROAT AND COUGH RESPOSNE . ALL THIS DATA WOULD BE ENTRED IN EXCEL SHEET AND FINAL RESULT WOULD BE CONCULUDED.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Double

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patient giving consent for study
  • Weight 40-70 kg
  • ASA grade 1 & 2
  • Patients undergoing surgery under general anaesthesia
  • All lab investigations within normal range.

Exclusion Criteria

  • Patient with a history of sore throat or upper respiratory tract infection
  • Hemodynamically unstable patients
  • Emergency patients
  • Patients with a history of allergy to local anesthetics
  • Patents with a history of allergy to dexmedetomidine
  • Patients with a history of cardiac, liver, or renal disorders.
  • Patient with a difficult airway where the anticipated duration of laryngoscopy exceeded 15 seconds.
  • ASA 3 and 4.

Outcomes

Primary Outcomes

.To access and compare they hemodynamic changes HR , SBP, DBP,MAP, Spo2 and ETco2 in both the groups

Time Frame: Before Nebulization ,After Nebulization, Before Intubation ,After Intubation, 5 minute after intubation ,at skin closure ,after extubation, 5 minutes after extubation

Secondary Outcomes

  • 1. To compare the cough response at extubation in both the groups.(2. The incidence rate of postoperative sore throat. In both the groups.)

Investigators

Sponsor
Ashu Agarwal
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Ashu Agarwal

Jhalawar medical college Jhalawar

Study Sites (1)

Loading locations...

Similar Trials